Core C, Research Translation Core: The primary goals of the Penn-SRP Center's Research Translation Core are to translate the knowledge and discoveries of the Center into actionable items that will remediate asbestos waste and reduce its adverse health effects, by forging productive partnerships with the public and private sectors. These partnerships will provide for technology transfer of substantive research outcomes to specific end-users that will benefit from this knowledge in addressing the myriad of remediation, ecological challenges and public health aspects that asbestos cleanups present to regulatory agencies even to this day. Currently ten states still have active hazardous waste sites that present significant risk from asbestos exposure. Our long term goal is to implement a new approach to risk assessment using biomarker panels to distinguish between asbestos exposed individuals that are disease free and those that may succumb to asbestos related disease. To enable these technologies the Core will form partnerships with government agencies in including the US Environmental Protection Agency (EPA) and the Agency for Toxic Substances and Disease Registry (ATSDR) and will promote the application of technologies based on the environmental and environmental health sciences research of the Penn-SRP that are consistent with EPA's Risk Assessment Guidance for Superfund (RAGS) and may be used as a model approach to enhance Volume I: Parts A-F of RAGS. These goals will be met under the following four Specific Aims:
Aim 1 : To communicate scientific advances within the Penn SRP as well as to the greater SRP community. The Core will work with project and core investigators to identify deliverables and coordinate research translation opportunities. It will pursue research translation opportunities emanating from the goals of the overall Center and report its activity within the SRP, to SRP staff at NIEHS and other SRP Centers.
Aim 2 : To form partnerships with government agencies. The Core will strengthen the capacity of U.S. EPA decision-making officials in both the Superfund Program and the Office of Research and Development by conducting peer-reviewed scientific investigations that will enhance human and ecological safeguards in the public and private sectors. It will develop active partnerships and communication tools with staff at the headquarters and regional offices of the EPA &ATSDR (HHS) to promote technical and policy applications on how our remediation strategies and biomarker work can help remediate asbestos containing sites and enhance risk-assessment.
Aim 3 : To translate findings into products through use of Technology Transfer. The Core will use its Technology Development and Transfer Committee to identify the non-biomedical and biomedical technologies that should be advanced through the intellectual property process into products and patents.
Aim 4 : To disseminate information to other end users. To promote innovative and cost-effective alternatives to protect the environment and public health the Core will develop communication tools and strategies to inform communities, hazardous waste practitioners and public health professionals, and the lay public of advances made by the Penn-SRP.
The primary goals of the Penn-Superfund Research Program (SRP) Center's Research Translation Core are to translate the knowledge and discoveries of the Center into actionable items by forging productive partnerships with the public and private sectors. These partnerships will provide for technology transfer of substantive research outcomes to specific end-users that will benefit from this knowledge in addressing the myriad of challenges that asbestos cleanups present to regulatory agencies even to this day. To enable these technologies the Core will form partnerships with government agencies in including the US Environmental Protection Agency (EPA) and the Agency for Toxic Substances and Disease Registry (ATSDR) and will promote the application of technologies based on research of the Penn-SRP.
|Salamatipour, Ashkan; Mohanty, Sanjay K; Pietrofesa, Ralph A et al. (2016) Asbestos Fiber Preparation Methods Affect Fiber Toxicity. Environ Sci Technol Lett 3:270-274|
|Clapp, Justin T; Roberts, Jody A; Dahlberg, Britt et al. (2016) Realities of environmental toxicity and their ramifications for community engagement. Soc Sci Med 170:143-151|
|Pietrofesa, Ralph A; Velalopoulou, Anastasia; Lehman, Stacey L et al. (2016) Novel Double-Hit Model of Radiation and Hyperoxia-Induced Oxidative Cell Damage Relevant to Space Travel. Int J Mol Sci 17:|
|Frey, Alexander J; Wang, Qingqing; Busch, Christine et al. (2016) Validation of highly sensitive simultaneous targeted and untargeted analysis of keto-steroids by Girard P derivatization and stable isotope dilution-liquid chromatography-high resolution mass spectrometry. Steroids 116:60-66|
|Pietrofesa, Ralph A; Velalopoulou, Anastasia; Arguiri, Evguenia et al. (2016) Flaxseed lignans enriched in secoisolariciresinol diglucoside prevent acute asbestos-induced peritoneal inflammation in mice. Carcinogenesis 37:177-87|
|Guo, Lili; Worth, Andrew J; Mesaros, Clementina et al. (2016) Diisopropylethylamine/hexafluoroisopropanol-mediated ion-pairing ultra-high-performance liquid chromatography/mass spectrometry for phosphate and carboxylate metabolite analysis: utility for studying cellular metabolism. Rapid Commun Mass Spectrom 30:1835-45|
|Kadariya, Yuwaraj; Menges, Craig W; Talarchek, Jacqueline et al. (2016) Inflammation-Related IL1Î²/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma. Cancer Prev Res (Phila) 9:406-14|
|Kadariya, Yuwaraj; Cheung, Mitchell; Xu, Jinfei et al. (2016) Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Cancer Res 76:2836-44|
|Ohar, Jill A; Cheung, Mitchell; Talarchek, Jacqueline et al. (2016) Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Cancer Res 76:206-15|
|Mesaros, Clementina; Blair, Ian A (2016) Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clin Proteomics 13:20|
Showing the most recent 10 out of 20 publications